Efficacy and Safety of COMBIGAN® in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension Glaucoma (NTG)
Study Identifier
CMO-AP-EYE-0428
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Study Details
Medical Condition
Study Drug
Phase
Phase 4
Sex
Female & Male
Age
18+ years
Protocol Summary
The objective of this study is to evaluate the long-term efficacy and safety of COMBIGAN® (brimonidine tartrate/timolol malate) in patients only using COMBIGAN® (brimonidine tartrate/timolol malate) and also in patients who require additional IOP lowering with LUMIGAN® (bimatoprost) 0.01%.
Study Locations
Location
Status
Location
Pusan National University Hospital, Pusan National University School of Medicine
Busan, Republic of Korea, 49241
Status
Not applicable
Location
Yeungnam University Hospital, Yeungnam University College of Medicine
Daegu, Republic of Korea, 42415
Status
Not applicable
Location
Chungnam National University Hospital, Chungnam National University College of Medicine
Daejeon, Republic of Korea, 35015
Status
Not applicable
Location
Chonnam National University Hospital, Chonnam National University Medical School
Gwangju, Republic of Korea, 61469
Status
Not applicable
Location
Seoul National University Bundang Hospital, Seoul National University College of Medicine
Gyeonggi-do, Republic of Korea, 13619
Status
Not applicable
Location
Seoul National University Hospital, Seoul National University College of Medicine
Seoul, Republic of Korea, 03080
Status
Not applicable
Showing {first} - {last} of {total} Results